首页|血清G-17、PGR、CEA、CA19-9及脂联素联合检测在胃癌筛查中的应用研究

血清G-17、PGR、CEA、CA19-9及脂联素联合检测在胃癌筛查中的应用研究

扫码查看
目的 探讨血清胃泌素-17(G-17)、胃蛋白酶原比值(PGR)、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)及脂联素联合检测在胃癌筛查中的应用价值.方法 选取58例胃癌患者作为观察组,同期收治的胃良性疾病患者58例设为对照组.所有患者均采集空腹静脉血检测G-17、PGR、CEA、CA19-9及脂联素水平,比较两组血清学指标差异及不同分期胃癌患者血清学指标变化;并绘制ROC曲线,分析血清G-17、PGR、CEA、CA19-9、脂联素单独检测及联合检测诊断胃癌的临床价值.结果 观察组 G-17[(16.25±2.18)pmol/L]、CEA[(12.84±2.13)ng/mL]、CA19-9[(42.53± 4.28)U/mL]水平高于对照组,PGR[(4.89±0.42)]、脂联素[(5.21±1.05)μg/mL]低于对照组,差异有统计学意义(P<0.05);Ⅰ~Ⅱ 期胃癌患者 G-17[(14.58±1.69)pmol/L]、CEA[(8.64±1.32)ng/mL]、CA19-9[(36.59±4.02)U/mL]水平低于Ⅲ~Ⅳ期患者,PGR[(6.15±1.02)]、脂联素[(7.02±1.15)μg/mL]高于Ⅲ~Ⅳ期患者,差异有统计学意义(P<0.05);绘制ROC曲线分析显示,G-17、PGR、CEA、CA19-9、脂联素单独检测及联合检测诊断胃癌的曲线下面积(AUC)分别为:0.782、0.775、0.784、0.786、0.722、0.950,联合检测诊断价值最高.结论 血清G-17、PGR、CEA、CA19-9及脂联素联合检测在胃癌筛查中应用价值高,可提高诊断效能,便于临床早期筛查工作开展.
Application of Combined Detection of Serum G-17,PGR,CEA,CA19-9 and Adiponectin in Gastric Cancer Screening
Objective To explore the value of combined detection of serum gastrin-17(G-17),pepsinogen ratio(PGR),carcinoembryonic antigen(CEA),carbohydrate antigen 19-9(CA19-9)and adiponectin in gastric cancer screening.Methods 58 patients with gastric cancer were selected as the observation group,and 58 patients with benign gastric diseases were selected as the control group.Fasting venous blood was collected from all patients to detect the levels of G-17,PGR,CEA,CA19-9 and adi-ponectin.The differences of serological indexes between the 2 groups and the changes of serological indexes in patients with differ-ent stages of gastric cancer were compared;The ROC curve was drawn to analyze the clinical value of serum G-17,PGR,CEA,CA19-9 and adiponectin in the diagnosis of gastric cancer.Results The levels of g-17[(16.25±2.18)pmol/l],cea[(12.84± 2.13)ng/ml],cal9-9[(42.53±4.28)U/ml]in the observation group were higher than those in the control group,pgr[(4.89 ±0.42)],adiponectin[(5.21±1.05)μG/ml]was lower than that of the control group,and the difference was statistically sig-nificant(P<0.05);The levels of g-17[(14.58±1.69)pmol/l],cea[(8.64±1.32)ng/ml],ca19-9[(36.59±4.02)u/ml]in patients with stage Ⅰ~Ⅱ gastric cancer were lower than those in patients with stage Ⅲ~Ⅳ,pgr[(6.15±1.02)],adiponectin[(7.02±1.15)μG/ml]was higher than that of stage Ⅲ~Ⅳ patients,and the difference was statistically significant(P<0.05);The ROC curve analysis showed that the area under the curve(AUC)of G-17,PGR,CEA,CA19-9 and adiponectin for the diagnosis of gastric cancer were 0.782,0.775,0.784,0.786,0.722 and 0.950 respectively,and the diagnostic value of combined detection was the highest.Conclusion the combined detection of serum G-17,PGR,CEA,CA19-9 and adiponectin is of high value in gastric cancer screening,which can improve the diagnostic efficiency and facilitate the early clinical screening.

Gastric cancerGas trin-17Pepsinogen ratioCarcinoembryonic antigenCarbohydrate antigen 19-9Disease screening

曹霞、张佳盈、徐满

展开 >

475000 河南省开封市中心医院

胃癌 胃泌素-17 胃蛋白酶原比值 癌胚抗原 糖类抗原19-9 疾病筛查

2024

实用癌症杂志
江西省肿瘤医院 江西省肿瘤研究所

实用癌症杂志

影响因子:1.241
ISSN:1001-5930
年,卷(期):2024.39(1)
  • 12